10x Genomics, Inc. Debt Securities, Available-for-sale, Realized Gain
10x Genomics, Inc. (TXG) reported Debt Securities, Available-for-sale, Realized Gain of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-15.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGain · last filed 2024-10-29
- 10x Genomics, Inc. debt securities, available-for-sale, realized gain for the quarter ending 2023-12-31 was $0.00.
- 10x Genomics, Inc. debt securities, available-for-sale, realized gain for the quarter ending 2023-09-30 was $0.00.
- 10x Genomics, Inc. debt securities, available-for-sale, realized gain for the quarter ending 2023-06-30 was $0.00.
- 10x Genomics, Inc. debt securities, available-for-sale, realized gain for the quarter ending 2023-03-31 was $0.00.
- 10x Genomics, Inc. debt securities, available-for-sale, realized gain for fiscal 2023 was $0.00.
| Period end | Debt Securities, Available-for-sale, Realized Gain 3 month | Debt Securities, Available-for-sale, Realized Gain 6 month | Debt Securities, Available-for-sale, Realized Gain 9 month | Debt Securities, Available-for-sale, Realized Gain 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $0.00 derived: sum of 2 quarters · filed 2024-10-29 | $0.00 derived: sum of 3 quarters · filed 2024-10-29 | $0.00 10-K · filed 2024-02-15 |
| 2023-09-30 | $0.00 10-Q · filed 2024-10-29 | $0.00 derived: sum of 2 quarters · filed 2024-10-29 | $0.00 10-Q · filed 2024-10-29 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-04-30 | |||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-11-03 | $0.00 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 |